BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 9650357)

  • 21. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-blockers for treatment of hypertension.
    Basile JN; Cohen JD
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):11-7. PubMed ID: 19667665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control.
    Sarafidis PA; Bakris GL
    QJM; 2006 Jul; 99(7):431-6. PubMed ID: 16766516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension.
    Prichard BN; Saul PA
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S81-5. PubMed ID: 11527141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta-blockers and arterial hypertension. Evidence-based medicine or excessive perseverance?].
    Verdecchia P; Angeli F; Achilli P; Castellani C; Repaci S; Ambrosio G
    G Ital Cardiol (Rome); 2007 Sep; 8(9):552-8. PubMed ID: 17972424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Beta blockers in arterial hypertension].
    Leroy P
    Soins Cardiol; 1985; (28-29):31-8. PubMed ID: 2865815
    [No Abstract]   [Full Text] [Related]  

  • 29. [New aspects of differential therapy of arterial hypertension with beta-blockers].
    Schwartzkopff B; Strauer BE
    Z Kardiol; 1996; 85 Suppl 7():31-4. PubMed ID: 9082681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nebivolol: a third-generation beta-adrenergic blocker.
    Veverka A; Nuzum DS; Jolly JL
    Ann Pharmacother; 2006; 40(7-8):1353-60. PubMed ID: 16822893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-blockers and hypertension: carbon copies or a real choice.
    Whipps RG; Fisher ML; Plotnick GD
    Compr Ther; 1984 Sep; 10(9):12-8. PubMed ID: 6149036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Quality of life in patients treated with beta blockers].
    Simić D; Subota N
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():71-3. PubMed ID: 18193816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nebivolol: in the treatment of hypertension in the US.
    Baldwin CM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(4):253-60. PubMed ID: 19655820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving mechanisms of action of beta blockers: focus on nebivolol.
    Mason RP; Giles TD; Sowers JR
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):123-8. PubMed ID: 19528811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current position of beta-adrenergic blockers in the management of arterial hypertension].
    Rumboldt Z
    Lijec Vjesn; 2007; 129(6-7):237-40. PubMed ID: 18018716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittent blood pressure control: potential consequences for outcome.
    Leenen FH
    Can J Cardiol; 1999 May; 15 Suppl C():13C-18C. PubMed ID: 10380687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy with beta-adrenergic blockade and amlodipine as second line treatment in essential hypertension.
    Mettimano M; Pichetti F; Fazzari L; Migneco A; Specchia L; Romano Spica V; Savi L
    Int J Clin Pract; 2000 Sep; 54(7):424-8. PubMed ID: 11070565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of beta1-beta2-selectivity and intrinsic sympathomimetic activity in beta-blockers, with particular reference to antihypertensive treatment.
    Imhof P
    Adv Clin Pharmacol; 1976; 11():26-32. PubMed ID: 25568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.